SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4mh0'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FE2_A_LAXA700_2 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4mh0	RAS-RELATED PROTEIN RAP-1B (Homo sapiens)	5 / 12	TYR R 40 GLY R 60 ALA R 59 GLY R 10 LEU R 9	None None SO4 R 201 (-3.3A) None None	1.01A	1fe2A-4mh0R: undetectable	1fe2A-4mh0R: 16.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I18_A_RBFA98_1 (RIBOFLAVIN SYNTHASE ALPHA CHAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 10	LEU E 797 LEU E 769 ILE E 805 THR E 717 ILE E 718	None	1.37A	1i18A-4mh0E: undetectable 1i18B-4mh0E: undetectable	1i18A-4mh0E: 8.93 1i18B-4mh0E: 8.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I18_B_RBFB99_1 (RIBOFLAVIN SYNTHASE ALPHA CHAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 10	THR E 717 ILE E 718 LEU E 797 LEU E 769 ILE E 805	None	1.38A	1i18A-4mh0E: undetectable 1i18B-4mh0E: undetectable	1i18A-4mh0E: 8.93 1i18B-4mh0E: 8.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IGX_A_EPAA700_1 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4mh0	RAS-RELATED PROTEIN RAP-1B (Homo sapiens)	5 / 12	TYR R 40 GLY R 60 ALA R 59 GLY R 10 LEU R 9	None None SO4 R 201 (-3.3A) None None	1.02A	1igxA-4mh0R: undetectable	1igxA-4mh0R: 16.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JFF_B_TA1B601_1 (TUBULIN BETA CHAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 12	GLU E 775 LEU E 532 HIS E 519 LEU E 562 GLY E 571	None	1.09A	1jffB-4mh0E: undetectable	1jffB-4mh0E: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QW6_A_H4BA901_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	3 / 3	ARG E 801 VAL E 974 TRP E 808	None	1.28A	1qw6A-4mh0E: undetectable	1qw6A-4mh0E: 21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VAG_A_H4BA901_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	3 / 3	ARG E 801 VAL E 974 TRP E 808	None	1.27A	1vagA-4mh0E: undetectable	1vagA-4mh0E: 21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZVI_A_H4BA901_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	3 / 3	ARG E 801 VAL E 974 TRP E 808	None	1.24A	1zviA-4mh0E: undetectable	1zviA-4mh0E: 21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2COI_B_GBNB420_1 (BRANCHED CHAIN AMINOTRANSFERASE 1, CYTOSOLIC)	4mh0	RAS-RELATED PROTEIN RAP-1B (Homo sapiens)	5 / 10	TYR R 32 VAL R 21 GLY R 60 THR R 61 ALA R 59	None None None None SO4 R 201 (-3.3A)	1.31A	2coiA-4mh0R: undetectable 2coiB-4mh0R: undetectable	2coiA-4mh0R: 16.49 2coiB-4mh0R: 16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2COJ_B_GBNB420_1 (BRANCHED CHAIN AMINOTRANSFERASE 1, CYTOSOLIC)	4mh0	RAS-RELATED PROTEIN RAP-1B (Homo sapiens)	5 / 9	TYR R 32 VAL R 21 GLY R 60 THR R 61 ALA R 59	None None None None SO4 R 201 (-3.3A)	1.39A	2cojA-4mh0R: undetectable 2cojB-4mh0R: undetectable	2cojA-4mh0R: 16.49 2cojB-4mh0R: 16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HXF_B_TA1B601_1 (TUBULIN BETA CHAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 12	GLU E 775 LEU E 532 HIS E 519 LEU E 562 GLY E 571	None	1.10A	2hxfB-4mh0E: undetectable	2hxfB-4mh0E: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HXH_B_TA1B601_1 (TUBULIN BETA CHAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 12	GLU E 775 LEU E 532 HIS E 519 LEU E 562 GLY E 571	None	1.10A	2hxhB-4mh0E: undetectable	2hxhB-4mh0E: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IZQ_C_DVAC8_0 (GRAMICIDIN D)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	3 / 3	VAL E 810 TRP E 808 VAL E 974	None	0.99A	2izqC-4mh0E: undetectable 2izqD-4mh0E: undetectable	2izqC-4mh0E: 2.67 2izqD-4mh0E: 2.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P4N_B_TA1B601_1 (TUBULIN BETA CHAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 12	GLU E 775 LEU E 532 HIS E 519 LEU E 562 GLY E 571	None	1.10A	2p4nB-4mh0E: undetectable	2p4nB-4mh0E: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEB_A_HSMA145_1 (D7R4 PROTEIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 7	ILE R 36 ARG E 892 TYR R 40 TYR R 32	None	1.00A	2qebA-4mh0R: undetectable	2qebA-4mh0R: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEB_B_HSMB145_1 (D7R4 PROTEIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 7	ILE R 36 ARG E 892 TYR R 40 TYR R 32	None	1.00A	2qebB-4mh0R: undetectable	2qebB-4mh0R: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R2V_D_ACTD37_0 (GCN4 LEUCINE ZIPPER)	4mh0	RAS-RELATED PROTEIN RAP-1B (Homo sapiens)	3 / 3	LYS R 50 ARG R 163 VAL R 162	None	1.11A	2r2vC-4mh0R: undetectable 2r2vD-4mh0R: undetectable	2r2vC-4mh0R: 13.77 2r2vD-4mh0R: 13.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 6	ILE E 498 LEU E 500 LEU E 512 ASP E 509	None	0.81A	2rlfA-4mh0E: undetectable 2rlfD-4mh0E: undetectable	2rlfA-4mh0E: 5.31 2rlfD-4mh0E: 5.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_A_RBFA200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	ARG E 859 ARG E 979 GLN E 983 GLN R 99	None	1.49A	2vxaA-4mh0E: undetectable 2vxaC-4mh0E: undetectable 2vxaE-4mh0E: undetectable	2vxaA-4mh0E: 7.10 2vxaC-4mh0E: 7.10 2vxaE-4mh0E: 7.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_B_RBFB200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	ARG E 979 GLN E 983 ARG E 859 GLN R 99	None	1.48A	2vxaA-4mh0E: undetectable 2vxaB-4mh0E: undetectable 2vxaK-4mh0E: undetectable	2vxaA-4mh0E: 7.10 2vxaB-4mh0E: 7.10 2vxaK-4mh0E: 7.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_C_RBFC200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	ARG E 979 GLN E 983 ARG E 859 GLN R 99	None	1.49A	2vxaB-4mh0E: undetectable 2vxaC-4mh0E: undetectable 2vxaG-4mh0E: undetectable	2vxaB-4mh0E: 7.10 2vxaC-4mh0E: 7.10 2vxaG-4mh0E: 7.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_D_RBFD200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	ARG E 859 ARG E 979 GLN E 983 GLN R 99	None	1.48A	2vxaD-4mh0E: undetectable 2vxaF-4mh0E: undetectable 2vxaI-4mh0E: undetectable	2vxaD-4mh0E: 7.10 2vxaF-4mh0E: 7.10 2vxaI-4mh0E: 7.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_E_RBFE200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	ARG E 979 GLN E 983 ARG E 859 GLN R 99	None	1.49A	2vxaD-4mh0E: undetectable 2vxaE-4mh0E: undetectable 2vxaL-4mh0E: undetectable	2vxaD-4mh0E: 7.10 2vxaE-4mh0E: 7.10 2vxaL-4mh0E: 7.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_H_RBFH200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	GLN R 99 ARG E 979 GLN E 983 ARG E 859	None	1.45A	2vxaB-4mh0R: undetectable 2vxaG-4mh0R: undetectable 2vxaH-4mh0R: undetectable	2vxaB-4mh0R: 20.00 2vxaG-4mh0R: 20.00 2vxaH-4mh0R: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_I_RBFI200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	ARG E 979 GLN E 983 ARG E 859 GLN R 99	None	1.47A	2vxaH-4mh0E: undetectable 2vxaI-4mh0E: undetectable 2vxaJ-4mh0E: undetectable	2vxaH-4mh0E: 7.10 2vxaI-4mh0E: 7.10 2vxaJ-4mh0E: 7.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_J_RBFJ200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	GLN R 99 ARG E 859 ARG E 979 GLN E 983	None	1.46A	2vxaD-4mh0R: undetectable 2vxaJ-4mh0R: undetectable 2vxaL-4mh0R: undetectable	2vxaD-4mh0R: 20.00 2vxaJ-4mh0R: 20.00 2vxaL-4mh0R: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_K_RBFK200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	GLN R 99 ARG E 979 GLN E 983 ARG E 859	None	1.49A	2vxaH-4mh0R: undetectable 2vxaJ-4mh0R: undetectable 2vxaK-4mh0R: undetectable	2vxaH-4mh0R: 20.00 2vxaJ-4mh0R: 20.00 2vxaK-4mh0R: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_L_RBFL200_1 (DODECIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	GLN R 99 ARG E 979 GLN E 983 ARG E 859	None	1.46A	2vxaA-4mh0R: undetectable 2vxaK-4mh0R: undetectable 2vxaL-4mh0R: undetectable	2vxaA-4mh0R: 20.00 2vxaK-4mh0R: 20.00 2vxaL-4mh0R: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WBE_B_TA1B1439_1 (TUBULIN BETA-2B CHAIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 12	GLU E 775 LEU E 532 HIS E 519 LEU E 562 GLY E 571	None	1.09A	2wbeB-4mh0E: undetectable	2wbeB-4mh0E: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOG_C_DHIC8_0 (6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	3 / 3	SER E 541 GLY E 390 GLY E 392	HR4 E1002 (-3.2A) HR4 E1002 ( 4.9A) HR4 E1002 (-3.4A)	0.56A	3bogA-4mh0E: undetectable 3bogC-4mh0E: undetectable	3bogA-4mh0E: undetectable 3bogC-4mh0E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DCO_B_TA1B601_1 (BOVINE BETA TUBULIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 12	GLU E 775 LEU E 532 HIS E 519 LEU E 562 GLY E 571	None	1.10A	3dcoB-4mh0E: undetectable	3dcoB-4mh0E: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EDL_B_TA1B601_1 (BETA TUBULIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 12	GLU E 775 LEU E 532 HIS E 519 LEU E 562 GLY E 571	None	1.08A	3edlB-4mh0E: undetectable	3edlB-4mh0E: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM0_A_CHDA153_0 (ILEAL BILE ACID-BINDING PROTEIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 5	ILE E 975 THR E 746 PHE E 750 PHE E 829	None	1.07A	3em0A-4mh0E: undetectable	3em0A-4mh0E: 12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IZ0_B_TA1B820_1 (BETA TUBULIN, CHAIN B FROM PDB 1JFF)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	5 / 12	GLU E 775 LEU E 532 HIS E 519 LEU E 562 GLY E 571	None	1.08A	3iz0B-4mh0E: undetectable	3iz0B-4mh0E: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PP1_A_ACTA590_0 (DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 5	GLU E 576 LEU E 574 HIS E 774 GLY E 571	None	0.93A	3pp1A-4mh0E: undetectable	3pp1A-4mh0E: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S3V_A_TOPA193_1 (DIHYDROFOLATE REDUCTASE)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 5	ASP E 572 LEU E 573 ILE E 646 PRO E 645	None	1.21A	3s3vA-4mh0E: undetectable	3s3vA-4mh0E: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VKX_A_T3A301_1 (PROLIFERATING CELL NUCLEAR ANTIGEN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 6	MET E 933 PRO E 524 GLN E 527 PRO E 487	None	1.13A	3vkxA-4mh0E: undetectable	3vkxA-4mh0E: 18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AC9_C_DXCC1476_0 (MJ0495-LIKE PROTEIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 5	ILE E 779 ALA E 937 HIS E 519 MET E 517	None	1.17A	4ac9B-4mh0E: undetectable 4ac9C-4mh0E: undetectable	4ac9B-4mh0E: 22.48 4ac9C-4mh0E: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_C_DXCC1476_0 (TRANSLATION ELONGATION FACTOR SELB)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 5	ILE E 779 ALA E 937 HIS E 519 MET E 517	None	1.16A	4acaB-4mh0E: undetectable 4acaC-4mh0E: undetectable	4acaB-4mh0E: 22.48 4acaC-4mh0E: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EJJ_C_NCTC501_1 (CYTOCHROME P450 2A6)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 5	PHE E 403 PHE E 427 ILE E 379 GLY E 382	None	1.03A	4ejjC-4mh0E: undetectable	4ejjC-4mh0E: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4C_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 6	LYS E 643 PRO E 645 LEU E 769 GLU E 768	None	1.39A	4z4cA-4mh0E: undetectable	4z4cA-4mh0E: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G5G_A_ACTA1231_0 (PUTATIVE XANTHINE DEHYDROGENASE YAGR MOLYBDENUM-BINDING SU SUBUNIT PUTATIVE XANTHINE DEHYDROGENASE YAGT IRON-SULFUR-BINDING SUBUNIT)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	3 / 3	ARG E 785 THR E 715 ASP E 796	None	0.80A	5g5gA-4mh0E: 1.9 5g5gB-4mh0E: undetectable	5g5gA-4mh0E: 15.80 5g5gB-4mh0E: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IAO_C_URFC301_1 (BIFUNCTIONAL PROTEIN PYRR)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	3 / 3	ARG E 315 HIS E 426 ARG E 311	None	1.16A	5iaoC-4mh0E: undetectable	5iaoC-4mh0E: 14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IAO_F_URFF301_1 (BIFUNCTIONAL PROTEIN PYRR)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	3 / 3	ARG E 315 HIS E 426 ARG E 311	None	1.15A	5iaoF-4mh0E: undetectable	5iaoF-4mh0E: 14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L1F_D_6ZPD902_1 (GLUTAMATE RECEPTOR 2)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	5 / 10	PRO E 884 TYR R 71 ASN R 74 LEU R 56 ASN E 887	None	1.42A	5l1fD-4mh0E: 2.6	5l1fD-4mh0E: 22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M8R_A_MMSA511_1 (5,6-DIHYDROXYINDOLE- 2-CARBOXYLIC ACID OXIDASE)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 7	ASN E 794 LEU E 797 VAL E 670 SER E 711	None	1.04A	5m8rA-4mh0E: undetectable	5m8rA-4mh0E: 20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M8R_D_MMSD509_1 (5,6-DIHYDROXYINDOLE- 2-CARBOXYLIC ACID OXIDASE)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 (Mus musculus)	4 / 8	ASN E 794 LEU E 797 VAL E 670 SER E 711	None	1.01A	5m8rD-4mh0E: undetectable	5m8rD-4mh0E: 20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZY_A_CE3A1103_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Homo sapiens; Mus musculus)	4 / 8	THR R 65 GLN R 63 ASP E 796 GLY E 720	None	0.97A	5nzyA-4mh0R: undetectable	5nzyA-4mh0R: 18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OSR_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	4mh0	RAS-RELATED PROTEIN RAP-1B (Homo sapiens)	4 / 7	VAL R 114 ILE R 112 VAL R 8 ALA R 79	None	0.65A	5osrA-4mh0R: undetectable	5osrA-4mh0R: 18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DJZ_C_GMJC301_1 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	4mh0	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 RAS-RELATED PROTEIN RAP-1B (Mus musculus; Homo sapiens)	4 / 6	LEU E 893 ASP R 38 GLN R 43 GLU R 37	None	1.25A	6djzC-4mh0E: 1.6	6djzC-4mh0E: 14.68

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FE2_A_LAXA700_2","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4mh0","RAS-RELATED PROTEIN RAP-1B","Homo sapiens",5,"TYR R  40;GLY R  60;ALA R  59;GLY R  10;LEU R   9","None;None;SO4 R 201 (-3.3A);None;None","1.01A","1fe2A-4mh0R:undetectable","1fe2A-4mh0R:16.11"],["1I18_A_RBFA98_1","RIBOFLAVIN SYNTHASE ALPHA CHAIN;RIBOFLAVIN SYNTHASE ALPHA CHAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"LEU E 797;LEU E 769;ILE E 805;THR E 717;ILE E 718","None","1.37A","1i18A-4mh0E:undetectable;1i18B-4mh0E:undetectable","1i18A-4mh0E:8.93;1i18B-4mh0E:8.93"],["1I18_B_RBFB99_1","RIBOFLAVIN SYNTHASE ALPHA CHAIN;RIBOFLAVIN SYNTHASE ALPHA CHAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"THR E 717;ILE E 718;LEU E 797;LEU E 769;ILE E 805","None","1.38A","1i18A-4mh0E:undetectable;1i18B-4mh0E:undetectable","1i18A-4mh0E:8.93;1i18B-4mh0E:8.93"],["1IGX_A_EPAA700_1","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4mh0","RAS-RELATED PROTEIN RAP-1B","Homo sapiens",5,"TYR R  40;GLY R  60;ALA R  59;GLY R  10;LEU R   9","None;None;SO4 R 201 (-3.3A);None;None","1.02A","1igxA-4mh0R:undetectable","1igxA-4mh0R:16.11"],["1JFF_B_TA1B601_1","TUBULIN BETA CHAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"GLU E 775;LEU E 532;HIS E 519;LEU E 562;GLY E 571","None","1.09A","1jffB-4mh0E:undetectable","1jffB-4mh0E:21.99"],["1QW6_A_H4BA901_1","NITRIC-OXIDE SYNTHASE, BRAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",3,"ARG E 801;VAL E 974;TRP E 808","None","1.28A","1qw6A-4mh0E:undetectable","1qw6A-4mh0E:21.56"],["1VAG_A_H4BA901_1","NITRIC-OXIDE SYNTHASE, BRAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",3,"ARG E 801;VAL E 974;TRP E 808","None","1.27A","1vagA-4mh0E:undetectable","1vagA-4mh0E:21.56"],["1ZVI_A_H4BA901_1","NITRIC-OXIDE SYNTHASE, BRAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",3,"ARG E 801;VAL E 974;TRP E 808","None","1.24A","1zviA-4mh0E:undetectable","1zviA-4mh0E:21.56"],["2COI_B_GBNB420_1","BRANCHED CHAIN AMINOTRANSFERASE 1, CYTOSOLIC;BRANCHED CHAIN AMINOTRANSFERASE 1, CYTOSOLIC","4mh0","RAS-RELATED PROTEIN RAP-1B","Homo sapiens",5,"TYR R  32;VAL R  21;GLY R  60;THR R  61;ALA R  59","None;None;None;None;SO4 R 201 (-3.3A)","1.31A","2coiA-4mh0R:undetectable;2coiB-4mh0R:undetectable","2coiA-4mh0R:16.49;2coiB-4mh0R:16.49"],["2COJ_B_GBNB420_1","BRANCHED CHAIN AMINOTRANSFERASE 1, CYTOSOLIC;BRANCHED CHAIN AMINOTRANSFERASE 1, CYTOSOLIC","4mh0","RAS-RELATED PROTEIN RAP-1B","Homo sapiens",5,"TYR R  32;VAL R  21;GLY R  60;THR R  61;ALA R  59","None;None;None;None;SO4 R 201 (-3.3A)","1.39A","2cojA-4mh0R:undetectable;2cojB-4mh0R:undetectable","2cojA-4mh0R:16.49;2cojB-4mh0R:16.49"],["2HXF_B_TA1B601_1","TUBULIN BETA CHAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"GLU E 775;LEU E 532;HIS E 519;LEU E 562;GLY E 571","None","1.10A","2hxfB-4mh0E:undetectable","2hxfB-4mh0E:21.99"],["2HXH_B_TA1B601_1","TUBULIN BETA CHAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"GLU E 775;LEU E 532;HIS E 519;LEU E 562;GLY E 571","None","1.10A","2hxhB-4mh0E:undetectable","2hxhB-4mh0E:21.99"],["2IZQ_C_DVAC8_0","GRAMICIDIN D","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",3,"VAL E 810;TRP E 808;VAL E 974","None","0.99A","2izqC-4mh0E:undetectable;2izqD-4mh0E:undetectable","2izqC-4mh0E:2.67;2izqD-4mh0E:2.67"],["2P4N_B_TA1B601_1","TUBULIN BETA CHAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"GLU E 775;LEU E 532;HIS E 519;LEU E 562;GLY E 571","None","1.10A","2p4nB-4mh0E:undetectable","2p4nB-4mh0E:21.99"],["2QEB_A_HSMA145_1","D7R4 PROTEIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"ILE R  36;ARG E 892;TYR R  40;TYR R  32","None","1.00A","2qebA-4mh0R:undetectable","2qebA-4mh0R:22.45"],["2QEB_B_HSMB145_1","D7R4 PROTEIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"ILE R  36;ARG E 892;TYR R  40;TYR R  32","None","1.00A","2qebB-4mh0R:undetectable","2qebB-4mh0R:22.45"],["2R2V_D_ACTD37_0","GCN4 LEUCINE ZIPPER","4mh0","RAS-RELATED PROTEIN RAP-1B","Homo sapiens",3,"LYS R  50;ARG R 163;VAL R 162","None","1.11A","2r2vC-4mh0R:undetectable;2r2vD-4mh0R:undetectable","2r2vC-4mh0R:13.77;2r2vD-4mh0R:13.77"],["2RLF_D_RIMD499_1","MATRIX PROTEIN 2;MATRIX PROTEIN 2","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"ILE E 498;LEU E 500;LEU E 512;ASP E 509","None","0.81A","2rlfA-4mh0E:undetectable;2rlfD-4mh0E:undetectable","2rlfA-4mh0E:5.31;2rlfD-4mh0E:5.31"],["2VXA_A_RBFA200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"ARG E 859;ARG E 979;GLN E 983;GLN R  99","None","1.49A","2vxaA-4mh0E:undetectable;2vxaC-4mh0E:undetectable;2vxaE-4mh0E:undetectable","2vxaA-4mh0E:7.10;2vxaC-4mh0E:7.10;2vxaE-4mh0E:7.10"],["2VXA_B_RBFB200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"ARG E 979;GLN E 983;ARG E 859;GLN R  99","None","1.48A","2vxaA-4mh0E:undetectable;2vxaB-4mh0E:undetectable;2vxaK-4mh0E:undetectable","2vxaA-4mh0E:7.10;2vxaB-4mh0E:7.10;2vxaK-4mh0E:7.10"],["2VXA_C_RBFC200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"ARG E 979;GLN E 983;ARG E 859;GLN R  99","None","1.49A","2vxaB-4mh0E:undetectable;2vxaC-4mh0E:undetectable;2vxaG-4mh0E:undetectable","2vxaB-4mh0E:7.10;2vxaC-4mh0E:7.10;2vxaG-4mh0E:7.10"],["2VXA_D_RBFD200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"ARG E 859;ARG E 979;GLN E 983;GLN R  99","None","1.48A","2vxaD-4mh0E:undetectable;2vxaF-4mh0E:undetectable;2vxaI-4mh0E:undetectable","2vxaD-4mh0E:7.10;2vxaF-4mh0E:7.10;2vxaI-4mh0E:7.10"],["2VXA_E_RBFE200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"ARG E 979;GLN E 983;ARG E 859;GLN R  99","None","1.49A","2vxaD-4mh0E:undetectable;2vxaE-4mh0E:undetectable;2vxaL-4mh0E:undetectable","2vxaD-4mh0E:7.10;2vxaE-4mh0E:7.10;2vxaL-4mh0E:7.10"],["2VXA_H_RBFH200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"GLN R  99;ARG E 979;GLN E 983;ARG E 859","None","1.45A","2vxaB-4mh0R:undetectable;2vxaG-4mh0R:undetectable;2vxaH-4mh0R:undetectable","2vxaB-4mh0R:20.00;2vxaG-4mh0R:20.00;2vxaH-4mh0R:20.00"],["2VXA_I_RBFI200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"ARG E 979;GLN E 983;ARG E 859;GLN R  99","None","1.47A","2vxaH-4mh0E:undetectable;2vxaI-4mh0E:undetectable;2vxaJ-4mh0E:undetectable","2vxaH-4mh0E:7.10;2vxaI-4mh0E:7.10;2vxaJ-4mh0E:7.10"],["2VXA_J_RBFJ200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"GLN R  99;ARG E 859;ARG E 979;GLN E 983","None","1.46A","2vxaD-4mh0R:undetectable;2vxaJ-4mh0R:undetectable;2vxaL-4mh0R:undetectable","2vxaD-4mh0R:20.00;2vxaJ-4mh0R:20.00;2vxaL-4mh0R:20.00"],["2VXA_K_RBFK200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"GLN R  99;ARG E 979;GLN E 983;ARG E 859","None","1.49A","2vxaH-4mh0R:undetectable;2vxaJ-4mh0R:undetectable;2vxaK-4mh0R:undetectable","2vxaH-4mh0R:20.00;2vxaJ-4mh0R:20.00;2vxaK-4mh0R:20.00"],["2VXA_L_RBFL200_1","DODECIN;DODECIN;DODECIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"GLN R  99;ARG E 979;GLN E 983;ARG E 859","None","1.46A","2vxaA-4mh0R:undetectable;2vxaK-4mh0R:undetectable;2vxaL-4mh0R:undetectable","2vxaA-4mh0R:20.00;2vxaK-4mh0R:20.00;2vxaL-4mh0R:20.00"],["2WBE_B_TA1B1439_1","TUBULIN BETA-2B CHAIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"GLU E 775;LEU E 532;HIS E 519;LEU E 562;GLY E 571","None","1.09A","2wbeB-4mh0E:undetectable","2wbeB-4mh0E:21.99"],["3BOG_C_DHIC8_0","6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",3,"SER E 541;GLY E 390;GLY E 392","HR4 E1002 (-3.2A);HR4 E1002 ( 4.9A);HR4 E1002 (-3.4A)","0.56A","3bogA-4mh0E:undetectable;3bogC-4mh0E:undetectable","3bogA-4mh0E:undetectable;3bogC-4mh0E:undetectable"],["3DCO_B_TA1B601_1","BOVINE BETA TUBULIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"GLU E 775;LEU E 532;HIS E 519;LEU E 562;GLY E 571","None","1.10A","3dcoB-4mh0E:undetectable","3dcoB-4mh0E:21.99"],["3EDL_B_TA1B601_1","BETA TUBULIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"GLU E 775;LEU E 532;HIS E 519;LEU E 562;GLY E 571","None","1.08A","3edlB-4mh0E:undetectable","3edlB-4mh0E:21.99"],["3EM0_A_CHDA153_0","ILEAL BILE ACID-BINDING PROTEIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"ILE E 975;THR E 746;PHE E 750;PHE E 829","None","1.07A","3em0A-4mh0E:undetectable","3em0A-4mh0E:12.15"],["3IZ0_B_TA1B820_1","BETA TUBULIN, CHAIN B FROM PDB 1JFF","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",5,"GLU E 775;LEU E 532;HIS E 519;LEU E 562;GLY E 571","None","1.08A","3iz0B-4mh0E:undetectable","3iz0B-4mh0E:21.99"],["3PP1_A_ACTA590_0","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"GLU E 576;LEU E 574;HIS E 774;GLY E 571","None","0.93A","3pp1A-4mh0E:undetectable","3pp1A-4mh0E:19.07"],["3S3V_A_TOPA193_1","DIHYDROFOLATE REDUCTASE","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"ASP E 572;LEU E 573;ILE E 646;PRO E 645","None","1.21A","3s3vA-4mh0E:undetectable","3s3vA-4mh0E:15.77"],["3VKX_A_T3A301_1","PROLIFERATING CELL NUCLEAR ANTIGEN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"MET E 933;PRO E 524;GLN E 527;PRO E 487","None","1.13A","3vkxA-4mh0E:undetectable","3vkxA-4mh0E:18.87"],["4AC9_C_DXCC1476_0","MJ0495-LIKE PROTEIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"ILE E 779;ALA E 937;HIS E 519;MET E 517","None","1.17A","4ac9B-4mh0E:undetectable;4ac9C-4mh0E:undetectable","4ac9B-4mh0E:22.48;4ac9C-4mh0E:22.48"],["4ACA_C_DXCC1476_0","TRANSLATION ELONGATION FACTOR SELB","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"ILE E 779;ALA E 937;HIS E 519;MET E 517","None","1.16A","4acaB-4mh0E:undetectable;4acaC-4mh0E:undetectable","4acaB-4mh0E:22.48;4acaC-4mh0E:22.48"],["4EJJ_C_NCTC501_1","CYTOCHROME P450 2A6","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"PHE E 403;PHE E 427;ILE E 379;GLY E 382","None","1.03A","4ejjC-4mh0E:undetectable","4ejjC-4mh0E:23.24"],["4Z4C_A_IPHA904_0","PROTEIN ARGONAUTE-2","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"LYS E 643;PRO E 645;LEU E 769;GLU E 768","None","1.39A","4z4cA-4mh0E:undetectable","4z4cA-4mh0E:22.22"],["5G5G_A_ACTA1231_0","PUTATIVE XANTHINE DEHYDROGENASE YAGR MOLYBDENUM-BINDING SU SUBUNIT;PUTATIVE XANTHINE DEHYDROGENASE YAGT IRON-SULFUR-BINDING SUBUNIT","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",3,"ARG E 785;THR E 715;ASP E 796","None","0.80A","5g5gA-4mh0E:1.9;5g5gB-4mh0E:undetectable","5g5gA-4mh0E:15.80;5g5gB-4mh0E:20.39"],["5IAO_C_URFC301_1","BIFUNCTIONAL PROTEIN PYRR","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",3,"ARG E 315;HIS E 426;ARG E 311","None","1.16A","5iaoC-4mh0E:undetectable","5iaoC-4mh0E:14.90"],["5IAO_F_URFF301_1","BIFUNCTIONAL PROTEIN PYRR","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",3,"ARG E 315;HIS E 426;ARG E 311","None","1.15A","5iaoF-4mh0E:undetectable","5iaoF-4mh0E:14.90"],["5L1F_D_6ZPD902_1","GLUTAMATE RECEPTOR 2","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",5,"PRO E 884;TYR R  71;ASN R  74;LEU R  56;ASN E 887","None","1.42A","5l1fD-4mh0E:2.6","5l1fD-4mh0E:22.39"],["5M8R_A_MMSA511_1","5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACID OXIDASE","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"ASN E 794;LEU E 797;VAL E 670;SER E 711","None","1.04A","5m8rA-4mh0E:undetectable","5m8rA-4mh0E:20.14"],["5M8R_D_MMSD509_1","5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACID OXIDASE","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4","Mus musculus",4,"ASN E 794;LEU E 797;VAL E 670;SER E 711","None","1.01A","5m8rD-4mh0E:undetectable","5m8rD-4mh0E:20.14"],["5NZY_A_CE3A1103_1","DNA CROSS-LINK REPAIR 1A PROTEIN","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Homo sapiens;Mus musculus",4,"THR R  65;GLN R  63;ASP E 796;GLY E 720","None","0.97A","5nzyA-4mh0R:undetectable","5nzyA-4mh0R:18.91"],["5OSR_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","4mh0","RAS-RELATED PROTEIN RAP-1B","Homo sapiens",4,"VAL R 114;ILE R 112;VAL R   8;ALA R  79","None","0.65A","5osrA-4mh0R:undetectable","5osrA-4mh0R:18.84"],["6DJZ_C_GMJC301_1","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","4mh0","RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4;RAS-RELATED PROTEIN RAP-1B","Mus musculus;Homo sapiens",4,"LEU E 893;ASP R  38;GLN R  43;GLU R  37","None","1.25A","6djzC-4mh0E:1.6","6djzC-4mh0E:14.68"]]